Retrovirus Restriction Factors

Alce, 2004, APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein, J. Biol. Chem, 279, 34083, 10.1074/jbc.C400235200 Bassin, 1980, Macromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses, J. Virol, 35, 287, 10.1128/JVI.35.2.287-297.1980 Beale, 2004, Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes, J. Mol. Biol, 337, 585, 10.1016/j.jmb.2004.01.046 Benit, 1997, Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene, J. Virol, 71, 5652, 10.1128/JVI.71.7.5652-5657.1997 Berkhout, 1994, The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins, Nucleic Acids Res, 22, 1705, 10.1093/nar/22.9.1705 Besnier, 2002, Restriction of lentivirus in monkeys, Proc. Natl. Acad. Sci. USA, 99, 11920, 10.1073/pnas.172384599 Besnier, 2003, Characterization of murine leukemia virus restriction in mammals, J. Virol, 77, 13403, 10.1128/JVI.77.24.13403-13406.2003 Best, 1996, Positional cloning of the mouse retrovirus restriction gene Fv1, Nature, 382, 826, 10.1038/382826a0 Bick, 2003, Expression of the zinc-finger antiviral protein inhibits alphavirus replication, J. Virol, 77, 11555, 10.1128/JVI.77.21.11555-11562.2003 Bishop, 2004, Cytidine deamination of retroviral DNA by diverse APOBEC proteins, Curr. Biol, 14, 1392, 10.1016/j.cub.2004.06.057 Bishop, 2004, APOBEC-mediated editing of viral RNA, Science, 305, 645, 10.1126/science.1100658 Bogerd, 2004, A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor, Proc. Natl. Acad. Sci. USA, 101, 3770, 10.1073/pnas.0307713101 Borden, 2002, Pondering the promyelocytic leukemia protein (PML) puzzle, Mol. Cell. Biol, 22, 5259, 10.1128/MCB.22.15.5259-5269.2002 Braaten, 2001, Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells, EMBO J, 20, 1300, 10.1093/emboj/20.6.1300 Braaten, 1996, Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription, J. Virol, 70, 3551, 10.1128/JVI.70.6.3551-3560.1996 Cen, 2004, The interaction between HIV-1 Gag and APOBEC3G, J. Biol. Chem, 279, 33177, 10.1074/jbc.M402062200 Conticello, 2003, The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G, Curr. Biol, 13, 2009, 10.1016/j.cub.2003.10.034 Cowan, 2002, Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism, Proc. Natl. Acad. Sci. USA, 99, 11914, 10.1073/pnas.162299499 de The, 1991, The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR, Cell, 66, 675, 10.1016/0092-8674(91)90113-D Decker, 1998, The exosome, Curr. Biol, 8, R238, 10.1016/S0960-9822(98)70149-6 DesGroseillers, 1983, Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses, J. Virol, 48, 685, 10.1128/JVI.48.3.685-696.1983 Dorfman, 1996, The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811, J. Virol, 70, 5751, 10.1128/JVI.70.9.5751-5757.1996 Duran-Troise, 1981, Balb/3T3 cells chronically infected with N-tropic murine leukemia virus continue to express Fv-1b restriction, Virology, 112, 795, 10.1016/0042-6822(81)90329-9 Franke, 1994, Specific incorporation of cyclophilin A into HIV-1 virions, Nature, 372, 359, 10.1038/372359a0 Gamble, 1996, Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid, Cell, 87, 1285, 10.1016/S0092-8674(00)81823-1 Gao, 2002, Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein, Science, 297, 1703, 10.1126/science.1074276 Goff, 1996, Operating under a Gag order, Cell, 86, 691, 10.1016/S0092-8674(00)80141-5 Guo, 2004, The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs, J. Virol, 78, 12781, 10.1128/JVI.78.23.12781-12787.2004 Harris, 2003, DNA deamination mediates innate immunity to retroviral infection, Cell, 113, 803, 10.1016/S0092-8674(03)00423-9 Harris, 2003, DNA deamination, Nat. Immunol, 4, 641, 10.1038/ni0703-641 Hatziioannou, 2003, Restriction of multiple divergent retroviruses by Lv1 and Ref1, EMBO J, 22, 385, 10.1093/emboj/cdg042 Hatziioannou, 2004, Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid, J. Virol, 78, 6005, 10.1128/JVI.78.11.6005-6012.2004 Hatziioannou, 2004, Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha, Proc. Natl. Acad. Sci. USA, 101, 10774, 10.1073/pnas.0402361101 Henry, 1998, B30.2-like domain proteins, Mol. Biol. Evol, 15, 1696, 10.1093/oxfordjournals.molbev.a025896 Himathongkham, 1996, Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells, Virology, 219, 485, 10.1006/viro.1996.0276 Hofmann, 1999, Species-specific, postentry barriers to primate immunodeficiency virus infection, J. Virol, 73, 10020, 10.1128/JVI.73.12.10020-10028.1999 Ikeda, 1985, Characterization of a molecularly cloned retroviral sequence associated with Fv-4 resistance, J. Virol, 55, 768, 10.1128/JVI.55.3.768-777.1985 Ikeda, 1989, Fv-4 resistance gene, J. Virol, 63, 5405, 10.1128/JVI.63.12.5405-5412.1989 Ikeda, 2004, Influence of gag on human immunodeficiency virus type 1 species-specific tropism, J. Virol, 78, 11816, 10.1128/JVI.78.21.11816-11822.2004 Kai, 1976, Mouse strain resistant to N-, B-, and NB-tropic murine leukemia viruses, J. Virol, 20, 436, 10.1128/JVI.20.2.436-440.1976 Kai, 1986, Relationship between the cellular resistance to Friend murine leukemia virus infection and the expression of murine leukemia virus-gp70-related glycoprotein on cell surface of BALB/c-Fv-4wr mice, Virology, 150, 509, 10.1016/0042-6822(86)90315-6 Kao, 2003, Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection, J. Virol, 77, 1131, 10.1128/JVI.77.2.1131-1140.2003 Kao, 2003, The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity, J. Virol, 77, 11398, 10.1128/JVI.77.21.11398-11407.2003 Kao, 2004, Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells, Retrovirology, 1, 27, 10.1186/1742-4690-1-27 Keckesova, 2004, The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities, Proc. Natl. Acad. Sci. USA, 101, 10780, 10.1073/pnas.0402474101 Kobayashi, 2004, APOBEC3G targets specific virus species, J. Virol, 78, 8238, 10.1128/JVI.78.15.8238-8244.2004 Kootstra, 2003, Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells, Proc. Natl. Acad. Sci. USA, 100, 1298, 10.1073/pnas.0337541100 Kozak, 1996, Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance, Virology, 225, 300, 10.1006/viro.1996.0604 Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 Lecossier, 2003, Hypermutation of HIV-1 DNA in the absence of the Vif protein, Science, 300, 1112, 10.1126/science.1083338 Liddament, 2004, APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo, Curr. Biol, 14, 1385, 10.1016/j.cub.2004.06.050 Lilly, 1967, Susceptibility to two strains of Friend leukemia virus in mice, Science, 155, 461, 10.1126/science.155.3761.461 Lilly, 1973, Genetic control of murine viral leukemogenesis, Adv. Cancer Res, 17, 231, 10.1016/S0065-230X(08)60532-1 Limjoco, 1993, Transgenic Fv-4 mice resistant to Friend virus, J. Virol, 67, 4163, 10.1128/JVI.67.7.4163-4168.1993 Liu, 2004, Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G, J. Virol, 78, 2072, 10.1128/JVI.78.4.2072-2081.2004 Luban, 1993, Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B, Cell, 73, 1067, 10.1016/0092-8674(93)90637-6 Luo, 2004, Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging, J. Virol, 78, 11841, 10.1128/JVI.78.21.11841-11852.2004 Madani, 1998, An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein, J. Virol, 72, 10251, 10.1128/JVI.72.12.10251-10255.1998 Mangeat, 2003, Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts, Nature, 424, 99, 10.1038/nature01709 Mangeat, 2004, A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action, J. Biol. Chem, 279, 14481, 10.1074/jbc.C400060200 Mariani, 2003, Species-specific exclusion of AOPBEC3G from HIV-1 virions by Vif, Cell, 114, 21, 10.1016/S0092-8674(03)00515-4 Marin, 2003, HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation, Nat. Med, 9, 1398, 10.1038/nm946 Mehle, 2004, Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway, J. Biol. Chem, 279, 7792, 10.1074/jbc.M313093200 Melchior, 2003, Sumo, Trends Biochem. Sci, 28, 612, 10.1016/j.tibs.2003.09.002 Meyer, 2003, Cluster of TRIM genes in the human MHC class I region sharing the B30.2 domain, Tissue Antigens, 61, 63, 10.1034/j.1399-0039.2003.610105.x Mitchell, 1997, The exosome, Cell, 91, 457, 10.1016/S0092-8674(00)80432-8 Munk, 2002, A dominant block to HIV-1 replication at reverse transcription in simian cells, Proc. Natl. Acad. Sci. USA, 99, 13843, 10.1073/pnas.212400099 Nisole, S., Lynch, C., Stoye, J.P., and Yap, M.W. (2004). A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. USA. Odaka, 1981, Fv-4, J. Natl. Cancer Inst, 67, 1123 Owens, 2003, Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells, J. Virol, 77, 726, 10.1128/JVI.77.1.726-731.2003 Owens, 2004, Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid, J. Virol, 78, 5423, 10.1128/JVI.78.10.5423-5437.2004 Perron, 2004, TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells, Proc. Natl. Acad. Sci. USA, 101, 11827, 10.1073/pnas.0403364101 Pincus, 1971, A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occuring viruses, J. Exp. Med, 133, 1219, 10.1084/jem.133.6.1219 Pincus, 1975, A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1 sensitive and resistant cell cultures, Virology, 65, 333, 10.1016/0042-6822(75)90039-2 Pryciak, 1992, Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro, J. Virol, 66, 5959, 10.1128/JVI.66.10.5959-5966.1992 Reymond, 2001, The tripartite motif family identifies cell compartments, EMBO J, 20, 2140, 10.1093/emboj/20.9.2140 Sayah, 2004, Selection for loss of Ref1 activity in human cells releases HIV-1 from cyclophilin A dependence during infection, J. Virol, 78, 12066, 10.1128/JVI.78.21.12066-12070.2004 Sayah, 2004, Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1, Nature, 430, 569, 10.1038/nature02777 Schafer, 2004, Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor, Virology, 328, 163, 10.1016/j.virol.2004.08.006 Schrofelbauer, 2004, A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif), Proc. Natl. Acad. Sci. USA, 101, 3927, 10.1073/pnas.0307132101 Schwartz, 1998, Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1, J. Virol, 72, 3845, 10.1128/JVI.72.5.3845-3850.1998 Shaheen, 2004, Co-receptor antagonists as HIV-1 entry inhibitors, Curr. Opin. Infect. Dis, 17, 7, 10.1097/00001432-200402000-00003 Sheehy, 2002, Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein, Nature, 418, 646, 10.1038/nature00939 Sheehy, 2003, The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif, Nat. Med, 9, 1404, 10.1038/nm945 Shibata, 1995, Early replication block of human immunodeficiency virus type 1 in monkey cells, J. Gen. Virol, 76, 2723, 10.1099/0022-1317-76-11-2723 Shindo, 2003, The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity, J. Biol. Chem, 278, 44412, 10.1074/jbc.C300376200 Simon, 1998, Evidence for a newly discovered cellular anti-HIV-1 phenotype, Nat. Med, 4, 1397, 10.1038/3987 Simon, 1998, The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted, EMBO J, 17, 1259, 10.1093/emboj/17.5.1259 Smit, 1999, Interspersed repeats and other mementos of transposable elements in mammalian genomes, Curr. Opin. Genet. Dev, 9, 657, 10.1016/S0959-437X(99)00031-3 Song, 2005, The B30.2 (SPRY) domain of the retroviral restriction factor TRIM5a exhibits lineage-specific length and sequence variation in primates, J. Virol, in press Stopak, 2003, HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability, Mol. Cell, 12, 591, 10.1016/S1097-2765(03)00353-8 Stoye, 2002, An intracellular block to primate lentivirus replication, Proc. Natl. Acad. Sci. USA, 99, 11549, 10.1073/pnas.192449399 Stremlau, 2004, The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys, Nature, 427, 848, 10.1038/nature02343 Suzuki, 1975, FV-4, Jpn. J. Exp. Med, 45, 473 Svarovskaia, 2004, Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs, J. Biol. Chem, 279, 35822, 10.1074/jbc.M405761200 Thali, 1994, Functional association of cyclophilin A with HIV-1 virions, Nature, 372, 363, 10.1038/372363a0 Towers, 2000, A conserved mechanism of retrovirus restriction in mammals, Proc. Natl. Acad. Sci. USA, 97, 12295, 10.1073/pnas.200286297 Towers, 2002, Abrogation of Ref1 retrovirus restriction in human cells, J. Virol, 76, 2548, 10.1128/jvi.76.5.2548-2550.2002 Towers, 2003, Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors, Nat. Med, 9, 1138, 10.1038/nm910 Turelli, 2004, Inhibition of hepatitis B virus replication by APOBEC3G, Science, 303, 1829, 10.1126/science.1092066 Turelli, 2004, The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay, J. Biol. Chem, 279, 43371, 10.1074/jbc.C400334200 Vajdos, 1997, Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein, Protein Sci, 6, 2297, 10.1002/pro.5560061103 Wichroski, M.J., Ichiyama, K., and Rana, T.M. (2004). Analysis of HIV-1 Vif-mediated proteasome-dependent depletion of APOBEC3G: Correlating function and subcellular localization. J. Biol. Chem., in press. Published online November 10, 2004. Wiegand, 2004, A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins, EMBO J, 23, 2451, 10.1038/sj.emboj.7600246 Xu, 2004, A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion, Proc. Natl. Acad. Sci. USA, 101, 5652, 10.1073/pnas.0400830101 Xu, 2003, BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta, Exp. Cell Res, 288, 84, 10.1016/S0014-4827(03)00187-3 Yap, 2003, Intracellular localisation of Fv1, Virology, 307, 76, 10.1016/S0042-6822(02)00053-3 Yap, 2004, Trim5alpha protein restricts both HIV-1 and murine leukemia virus, Proc. Natl. Acad. Sci. USA, 101, 10786, 10.1073/pnas.0402876101 Yoo, 1997, Molecular recognition in the HIV-1 capsid/cyclophilin A complex, J. Mol. Biol, 269, 780, 10.1006/jmbi.1997.1051 Yu, 2004, Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome, Nat Struct Mol Biol, 11, 435, 10.1038/nsmb758 Yu, 2003, Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex, Science, 302, 1056, 10.1126/science.1089591 Zennou, 2004, APOBEC3G incorporation into human immunodeficiency virus type 1 particles, J. Virol, 78, 12058, 10.1128/JVI.78.21.12058-12061.2004 Zhang, 2003, The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA, Nature, 424, 94, 10.1038/nature01707 Zheng, 2004, Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication, J. Virol, 78, 6073, 10.1128/JVI.78.11.6073-6076.2004